搜索





搜索





市场行情
/
股票
/
pvla
/

Palvella Therapeutics Inc

PVLA

添加自选

139.040USD

-11.150-7.42%

收盘 07-31 16:00（美东）报价延迟15分钟

1.99B总市值

亏损市盈率 TTM

Palvella Therapeutics Inc

139.040

-11.150-7.42%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

PVLA 利润表

您可以在这里找到Palvella Therapeutics Inc的年度或季度收入报告，以深入了解Palvella Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q3

FY2014Q2

FY2014Q1

营业总收入

----

-100.00%0.00

-97.26%53.00K

-77.78%1.30M

263.50%19.52M

442.32%20.05M

-82.38%1.94M

-30.76%5.85M

32.36%5.37M

12.57%3.70M

-29.71%10.99M

349.81%8.44M

38.04%4.06M

-70.79%3.29M

17.89%15.63M

-89.13%1.88M

-80.58%2.94M

110.92%11.25M

55.19%13.26M

251.44%17.27M

81.33%15.13M

-54.39%5.33M

105.80%8.54M

-72.93%4.91M

112.49%8.35M

530.97%11.69M

209.09%4.15M

565.83%18.15M

400.28%3.93M

72.70%1.85M

7.75%1.34M

27.42%2.73M

89.34%785.01K

569.52%1.07M

472.85%1.25M

--2.14M

2114.32%414.61K

-77.05%160.24K

-84.15%217.62K

--18.72K

--698.23K

--1.37M

营业收入

----

-100.00%0.00

-97.26%53.00K

-77.78%1.30M

263.50%19.52M

442.32%20.05M

-82.38%1.94M

-30.76%5.85M

32.36%5.37M

12.57%3.70M

-29.71%10.99M

349.81%8.44M

38.04%4.06M

-70.79%3.29M

17.89%15.63M

-89.13%1.88M

-80.58%2.94M

110.92%11.25M

55.19%13.26M

251.44%17.27M

81.33%15.13M

-54.39%5.33M

105.80%8.54M

-72.93%4.91M

112.49%8.35M

530.97%11.69M

209.09%4.15M

565.83%18.15M

400.28%3.93M

72.70%1.85M

7.75%1.34M

27.42%2.73M

89.34%785.01K

569.52%1.07M

472.85%1.25M

--2.14M

2114.32%414.61K

-77.05%160.24K

-84.15%217.62K

--18.72K

--698.23K

--1.37M

营业费用

88.73%14.86M

663.78%11.30M

224.63%10.18M

121.45%9.25M

347.47%7.87M

-75.57%1.48M

-67.46%3.13M

-74.54%4.18M

-88.59%1.76M

-65.11%6.06M

-45.07%9.63M

2.37%16.41M

-16.41%15.42M

-10.68%17.36M

-23.98%17.54M

-20.04%16.03M

-10.86%18.45M

36.07%19.44M

44.74%23.07M

26.07%20.05M

20.89%20.69M

-23.18%14.29M

-11.68%15.94M

-9.46%15.90M

-10.98%17.12M

5.91%18.60M

11.75%18.05M

26.04%17.56M

56.48%19.23M

50.56%17.56M

77.24%16.15M

43.00%13.93M

31.44%12.29M

27.74%11.66M

30.86%9.11M

41.87%9.74M

66.13%9.35M

94.08%9.13M

62.14%6.96M

85.90%6.87M

43.59%5.63M

--4.70M

130.91%4.29M

6.53%3.69M

91.72%3.92M

--1.86M

--3.47M

--2.04M

研发费用

129.11%9.33M

7.44%7.12M

1563.68%6.53M

581.49%5.12M

314.02%4.07M

48.81%6.63M

-104.65%-446.00K

-94.76%751.00K

-92.67%984.00K

-66.71%4.45M

-29.39%9.60M

19.93%14.33M

-4.56%13.42M

-12.87%13.38M

-28.24%13.59M

-24.39%11.95M

-15.07%14.07M

44.63%15.36M

60.18%18.94M

39.42%15.80M

29.82%16.56M

-24.78%10.62M

-10.51%11.82M

-15.25%11.33M

-10.76%12.76M

8.60%14.12M

15.88%13.21M

46.07%13.37M

80.14%14.30M

146.64%13.00M

82.15%11.40M

69.67%9.15M

48.06%7.94M

-23.81%5.27M

35.42%6.26M

19.90%5.40M

46.47%5.36M

135.06%6.92M

125.28%4.62M

160.79%4.50M

140.02%3.66M

--2.94M

121.42%2.05M

54.22%1.73M

24.69%1.52M

--926.60K

--1.12M

--1.22M

折旧摊销及损耗

----

-3.65%739.00K

30.02%758.00K

-28.40%605.00K

-5.58%575.00K

26.15%767.00K

-5.51%583.00K

35.20%845.00K

-11.48%609.00K

-19.36%608.00K

16.42%617.00K

84.37%625.00K

159.62%688.00K

374.21%754.00K

1161.90%530.00K

104.22%339.00K

35.90%265.00K

22.31%159.00K

-70.21%42.00K

23.88%166.00K

47.97%195.00K

137.07%130.00K

24.75%141.00K

33.54%134.00K

-29.14%131.79K

-40.80%54.84K

--113.03K

6.16%100.35K

151.89%186.00K

16.50%92.63K

----

21.00%94.52K

--73.84K

-11.05%79.51K

-18.61%76.44K

-18.24%78.12K

--89.39K

--93.91K

--95.55K

其他营业费用

----

107.33%53.00K

93.44%-446.00K

100.00%0.00

---723.00K

---6.80M

---1.58M

---2.03M

----

营业利润

-88.73%-14.86M

-663.78%-11.30M

-224.63%-10.18M

-121.45%-9.25M

-347.47%-7.87M

68.90%-1.48M

-131.71%-3.13M

-214.53%-4.18M

86.95%-1.76M

58.69%-4.76M

181.25%9.89M

129.58%3.65M

-80.81%-13.48M

-4.73%-11.52M

36.00%-12.17M

26.44%-12.33M

-47.40%-7.46M

11.38%-11.00M

-46.26%-19.01M

-260.06%-16.76M

-31.20%-5.06M

-833.16%-12.41M

-346.09%-13.00M

61.94%-4.66M

63.91%-3.86M

89.48%-1.33M

62.66%-2.91M

-445.25%-12.23M

-31.31%-10.68M

-294.96%-12.65M

-50.53%-7.80M

71.58%-2.24M

-1.63%-8.14M

201.29%6.49M

16.08%-5.18M

-36.17%-7.89M

-82.75%-8.01M

-149.67%-6.40M

-59.23%-6.18M

-63.97%-5.80M

-18.35%-4.38M

---2.57M

-110.74%-3.88M

-27.60%-3.53M

-451.44%-3.70M

---1.84M

---2.77M

---671.22K

净非营业利息收入（费用）

利息收入

42.69%1.07M

--520.00K

271.60%628.00K

243.28%690.00K

774.42%752.00K

----

-69.22%169.00K

-58.98%201.00K

-75.91%86.00K

29.63%455.00K

127.80%549.00K

271.21%490.00K

--357.00K

--351.00K

5925.00%241.00K

4300.00%132.00K

----

-92.73%4.00K

-97.67%3.00K

-99.06%3.00K

-97.91%8.00K

-85.41%55.00K

-71.27%129.00K

-36.96%319.00K

-18.90%382.00K

-25.20%377.00K

-32.18%449.00K

55.69%506.00K

210.41%471.00K

524900.00%504.00K

987959.70%662.00K

324900.00%325.00K

--151.74K

--96.00

--67.00

--100.00

----

利息费用

67.82%2.04M

-59.72%1.74M

--1.51M

--1.35M

50.93%1.22M

--4.32M

----

--805.00K

----

出售证券收益

----

---610.00K

----

特殊收入（费用）

214.67%86.00K

93.45%-99.00K

---320.00K

---118.00K

-29.31%-75.00K

-685.66%-1.51M

100.00%0.00

----

---58.00K

-92.39%258.00K

-1577.72%-21.69M

----

209.68%3.39M

-18.17%1.47M

48.74%1.18M

--2.13M

--1.09M

--1.79M

--796.00K

----

其他非经营性收入（费用）

-114.29%-32.00K

-104.96%-92.00K

-56.96%34.00K

45.34%561.00K

--224.00K

444.42%1.85M

-84.39%79.00K

339.75%386.00K

100.00%0.00

-65.54%-538.00K

-30.01%506.00K

-123.82%-161.00K

-124.89%-57.00K

-185.98%-325.00K

6.64%723.00K

45.69%676.00K

-74.10%229.00K

120.62%378.00K

150.63%678.00K

209.43%464.00K

1573.33%884.00K

-1135.59%-1.83M

-2334.55%-1.34M

-1943.48%-424.00K

64.91%-60.00K

-46.53%177.00K

-104.80%-55.00K

-98.13%23.00K

81.06%-171.00K

-66.73%331.00K

166.35%1.15M

189.14%1.23M

-7817.29%-903.00K

16694.23%994.89K

-9376.58%-1.73M

-1471.48%-1.38M

-94.67%11.70K

-21.85%5.92K

-845.72%-18.24K

-2058.10%-87.80K

28459.17%219.62K

--7.58K

-1403.38%-1.93K

115.47%4.48K

31.90%769.00

--148.00

--2.08K

--583.00

税前利润

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-222.75%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

80.76%-2.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.04%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-1746.43%-14.24M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

93.49%-771.00K

57.87%-2.59M

-3249.86%-11.76M

-18.75%-10.35M

-255.17%-11.85M

11.00%-6.15M

96.21%-351.00K

-9.01%-8.71M

219.34%7.63M

-11.57%-6.91M

-57.59%-9.27M

-92.11%-7.99M

-133.61%-6.40M

-59.62%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.74M

-91.96%-3.88M

-22.50%-3.53M

-375.01%-3.70M

---2.02M

---2.88M

---779.92K

所得税

--0.00

----

--0.00

----

--164.00K

----

100.00%0.00

--0.00

100.00%0.00

--0.00

-214.21%-164.00K

-100.00%0.00

-118.19%-148.00K

--0.00

-11.35%143.59K

--145.70K

--813.71K

--0.00

-0.89%161.97K

-100.00%0.00

--0.00

--163.43K

--40.44K

--0.00

100.00%0.00

--0.00

---18.00

除税后利润

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-222.75%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

80.76%-2.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-1767.70%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

93.40%-771.00K

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

持续经营利润

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-222.75%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

80.76%-2.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

43.46%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

-118.02%-25.47M

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

反常净利润

----

--0.00

----

其他净损益

----

---24.70M

----

归属于母公司的净利润

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-199.82%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

79.29%-2.73M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-299.89%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

69.17%-3.60M

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

优先股派息

----

--0.00

-100.00%0.00

--0.00

----

--194.00K

----

--2.83M

----

归属于普通股东的净利润

-92.63%-15.77M

-109.63%-12.71M

-292.97%-11.35M

-163.82%-9.47M

-199.82%-8.19M

-32.31%-6.07M

73.15%-2.89M

-190.29%-3.59M

79.29%-2.73M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

15.00%-8.10M

41.12%-9.74M

33.29%-10.34M

-22.27%-5.10M

33.81%-9.53M

-15.77%-16.54M

-213.09%-15.50M

-15.99%-4.17M

-299.89%-14.40M

-451.04%-14.28M

57.90%-4.95M

65.24%-3.60M

69.17%-3.60M

57.87%-2.59M

-5692.12%-11.76M

-18.75%-10.35M

-255.96%-11.68M

12.83%-6.15M

97.99%-203.00K

-9.01%-8.71M

214.21%7.49M

-13.92%-7.06M

-71.42%-10.08M

-92.11%-7.99M

-126.03%-6.56M

-57.98%-6.20M

-66.66%-5.88M

-12.32%-4.16M

---2.90M

-93.96%-3.92M

-22.50%-3.53M

-375.02%-3.70M

---2.02M

---2.88M

---779.90K

基本每股收益

-62.14%-1.20

10.86%-1.07

53.12%-1.03

68.99%-0.86

51.81%-0.74

67.57%-1.20

74.87%-2.19

-176.14%-2.76

89.10%-1.54

57.45%-3.70

16.89%-8.70

132.53%3.63

-155.65%-14.15

17.65%-8.71

46.40%-10.47

44.29%-11.16

6.63%-5.54

48.61%-10.57

7.11%-19.53

-164.86%-20.03

-13.75%-5.93

-279.12%-20.57

-400.48%-21.03

60.45%-7.56

67.97%-5.21

68.55%-5.43

53.83%-4.20

-6255.32%-19.12

-16.82%-16.27

-229.15%-17.26

28.47%-9.10

98.38%-0.30

6.20%-13.93

209.68%13.36

-10.53%-12.72

-61.36%-18.59

-77.70%-14.85

-108.96%-12.18

-42.67%-11.51

-20.03%-11.52

17.02%-8.36

---5.83

41.01%-8.07

50.76%-9.60

-375.02%-10.07

---13.68

---19.49

---2.12

稀释每股收益

-62.14%-1.20

10.86%-1.07

53.12%-1.03

68.99%-0.86

51.81%-0.74

67.57%-1.20

74.87%-2.19

-176.31%-2.76

89.10%-1.54

57.45%-3.70

16.89%-8.70

132.46%3.62

-155.65%-14.15

17.65%-8.71

46.40%-10.47

44.29%-11.16

6.63%-5.54

48.61%-10.57

7.11%-19.53

-164.86%-20.03

-13.75%-5.93

-279.12%-20.57

-400.48%-21.03

60.45%-7.56

67.97%-5.21

68.55%-5.43

53.83%-4.20

-6255.32%-19.12

-16.82%-16.27

-229.15%-17.26

28.47%-9.10

98.38%-0.30

6.20%-13.93

209.68%13.36

-10.53%-12.72

-61.36%-18.59

-77.70%-14.85

-108.96%-12.18

-42.67%-11.51

-20.03%-11.52

17.02%-8.36

---5.83

41.01%-8.07

50.76%-9.60

-375.02%-10.07

---13.68

---19.49

---2.12

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Palvella Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 PVLA 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Palvella Therapeutics Inc 全年的净利润是多少？



Palvella Therapeutics Inc 2025 财年净利润为 -41.72M。

Palvella Therapeutics Inc 上一季度的净利润是多少？



Palvella Therapeutics Inc 最近一个季度的净利润为 -15.77M。

Palvella Therapeutics Inc 年度营业利润是多少？



Palvella Therapeutics Inc 2025 财年的营业利润为 -38.60M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。